Fully Implantable Active Middle Ear Implants After Subtotal Petrosectomy With Fat Obliteration: Preliminary Clinical Results.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 14 7 2020
pubmed: 14 7 2020
medline: 15 4 2021
Statut: ppublish

Résumé

In patients with chronic middle ear disease, especially after revision surgery for ventilation problems and mixed hearing loss, active middle ear implants may provide an alternative treatment option. The fully implantable active middle-ear implant (FI-AMEI) is designed for implantation in a ventilated mastoid with an intact posterior canal wall. Until now, there have been no reports on audiometric results after implantation of a FI-AMEI in a fat-obliterated cavity after subtotal petrosectomy (SPE). Retrospective case review. Tertiary referral center. Twelve patients were included after numerous previous tympanoplasty surgeries for severe mixed hearing loss and FI-AMEI implantation. In five patients, the FI-AMEI was implanted in a cavity, with fat obliteration, after SPE. Seven patients received FI-AMEI implantation after intact canal wall (ICW) surgery. Audiometric results (pure-tone audiometry, Freiburger monosyllables) are demonstrated for 12 patients after an observation period of 3 months. The improvement in monosyllable score was 40 to 85% for the 12 patients. Free-field-aided thresholds showed high heterogeneity. FI-AMEI implantation combined with SPE provides an alternative approach to hearing rehabilitation to non-FI-AMEI implantation. Studies with a high number of patients and long-term observation periods are necessary to statistically verify these results.

Identifiants

pubmed: 32658109
doi: 10.1097/MAO.0000000000002797
pii: 00129492-202008000-00045
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e912-e920

Références

Zahnert T, Bornitz M, Hüttenbrink KB. Experiments on the coupling of an active middle ear implant to the stapes footplate. Adv Otorhinolaryngol 2010; 69:32–37.
Müller C, Zahnert T, Ossmann S, Neudert M, Bornitz M. Vibroplasty combined with tympanic membrane reconstruction in middle ear ventilation disorders. Hear Res 2019; 378:166–175.
Müller M, Salcher R, Lenarz T, Maier H. The Hannover Coupler: controlled static prestress in round window stimulation with the floating mass transducer. Otol Neurotol 2017; 38:1186–1192.
Beleites T, Neudert M, Bornitz M, Zahnert T. Sound transfer of active middle ear implants. Otolaryngol Clin North Am 2014; 47:859–891.
Ihler F, Köhler S, Meyer AC, et al. Mastoid cavity obliteration and Vibrant Soundbridge implantation for patients with mixed hearing loss. Laryngoscope 2014; 124:531–537.
Linder T, Schlegel C, DeMin N, van der Westhuizen S. Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery. Otol Neurotol 2009; 30:41–47.
Henseler MA, Polanski JF, Schlegel C, Linder T. Active middle ear implants in patients undergoing subtotal petrosectomy: long-term follow-up. Otol Neurotol 2014; 35:437–441.
Bruschini L, Berrettini S, Forli F, Murri A, Cuda D. The Carina© middle ear implant: surgical and functional outcomes. Eur Arch Otorhinolaryngol 2016; 273:3631–3640.
Bruschini L, Forli F, Passetti S, Bruschini P, Berrettini S. Fully implantable Otologics MET Carina(™) device for the treatment of sensorineural and mixed hearing loss: audio-otological results. Acta Otolaryngol (Stockh) 2010; 130:1147–1153.
Savaş VA, Gündüz B, Karamert R, et al. Comparison of Carina active middle-ear implant with conventional hearing aids for mixed hearing loss. J Laryngol Otol 2016; 130:340–343.
Martin C, Deveze A, Richard C, et al. European results with totally implantable carina placed on the round window: 2-year follow-up. Otol Neurotol 2009; 30:1196–1203.
Grossöhmichen M, Salcher R, Lenarz T, Maier H. The effect of simulated mastoid obliteration on the mechanical output of electromagnetic transducers. Otol Neurotol 2016; 37:919–925.
Liu Q, Feng G, Shang Y, Wang S, Gao Z. Vibrant soundbridge implantation: floating mass transducer coupled with the stapes head and embedded in fat. ORL J Otorhinolaryngol Relat Spec 2018; 80:59–64.
Becvarovski Z, Kartush JM. Smoking and tympanoplasty: implications for prognosis and the Middle Ear Risk Index (MERI). Laryngoscope 2001; 111:1806–1811.
Coker NJ, Jenkins HA, Fisch U. Obliteration of the middle ear and mastoid cleft in subtotal petrosectomy: indications, technique, and results. Ann Otol Rhinol Laryngol 1986; 95 (1 pt 1):5–11.
Mueller H, Killion M. An easy method for calculating the articulation index. Hear J 1990; 43:14–17.
Gurgel RK, Jackler RK, Dobie RA, Popelka GR. A new standardized format for reporting hearing outcome in clinical trials. Otolaryngol Head Neck Surg 2012; 147:803–807.
Maier H, Baumann U, Baumgartner W-D, et al. Minimal reporting standards for active middle ear hearing implants. Audiol Neurootol 2018; 23:105–115.
Schwab B, Kludt E, Maier H, Lenarz T, Teschner M. Subtotal petrosectomy and CodacsTM: new possibilities in ears with chronic infection. Eur Arch Otorhinolaryngol 2016; 273:1387–1391.
Free RH, Falcioni M, Di Trapani G, Giannuzzi AL, Russo A, Sanna M. The role of subtotal petrosectomy in cochlear implant surgery--a report of 32 cases and review on indications. Otol Neurotol 2013; 34:1033–1040.
Fisch U, Mattox D. Microsurgery of the Skull Base. Stuttgart, New York: Thieme; 1988.
Busch S, Lenarz T, Maier H. Comparison of alternative coupling methods of the vibrant soundbridge floating mass transducer. Audiol Neurootol 2016; 21:347–355.
Kludt E, Büchner A, Schwab B, Lenarz T, Maier H. Indication of direct acoustical cochlea stimulation in comparison to cochlear implants. Hear Res 2016; 340:185–190.

Auteurs

Nikoloz Lasurashvili (N)

Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Saxony, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH